Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
SAGE documentation
Measles
Type of publications
NITAG documentation (38)
SAGE documentation (14)
Scientific publications (1)
Systematic reviews (SYSVAC) (83)
Topics
Evidence to recommendation table (2)
GRADE table (6)
Meeting report (3)
Position paper (2)
SAGE background document (1)
Diseases
Measles (14)
Cholera (5)
COVID-19 (34)
Dengue (13)
Diphtheria (4)
Ebola (6)
Haemophilus influenzae type B (4)
Hepatitis A (11)
Hepatitis B (4)
Hepatitis E (2)
Herpes zoster (2)
Human papillomavirus (HPV) (18)
Influenza (17)
Japanese encephalitis (10)
Malaria (13)
Meningococcal disease (7)
Mpox (7)
Mumps (2)
Pertussis (4)
Pneumococcal disease (12)
Poliomyelitis (20)
Rabies (5)
Rotavirus (1)
RSV (Respiratory syncytial virus) (4)
Rubella (8)
Smallpox (1)
Tetanus (2)
Tick-borne encephalitis (1)
Tuberculosis (9)
Typhoid (8)
Varicella (3)
Yellow fever (3)
Show more
Publication date
2021 (1)
2020 (1)
2018 (1)
2017 (10)
2009 (1)
Available to download in languages
fr (1)
14 results found
2021
∙
SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, 22–24 March 2021: conclusions and recommendations
2020
∙
SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, March 2020: Conclusions and recommendations
2018
∙
SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, October 2018 – Conclusions and recommendations
2017
∙
SAGE
Effectiveness of measles vaccine in young children and adolescents
2017
∙
SAGE
Should SAGE recommend the removal of the criterion that MCV2 only be given if MCV1 coverage is >80% for the introduction of routine measles second dose as stated in the 2009 measles vaccine position paper?
2017
∙
SAGE
Systematic literature review and meta-analyses of the benefits and risks of measles vaccination below 6 months of age
2017
∙
SAGE
Safety of the measles vaccine in young children and adolescents
2017
∙
SAGE
Duration of protection following measles immunization
2017
∙
SAGE
Should an additional dose of measles-containing vaccine be recommended for HIV-infected adolescents and adults?
2017
∙
SAGE
Measles revaccination of HIV-infected children receiving highly active antiretroviral therapy
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register